耐药GNB感染抗菌治疗__培训课件.pptxVIP

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
耐药革兰阴性菌感染的抗菌治疗 Gram-negative bacilli account for over 70% of all clinical isolates in ChinaPercentage of Gram-negative bacilli in total clinical isolates (%)CHINET 2015Gram-positive cocci30%(26481/88778)Gram-negative bacilli70%(62297/88778)CHINET national bacterial resistance surveillance data革兰阴性菌的构成CHINET 2007-2014Constituent ratio of A. baumannii, P. aeruginosa and K. pneumoniae among all clinical isolates in China since 2005K. pneumoniae%A. baumanniiP. aeruginosaCHINET national bacterial resistance surveillance dataHu FP, Clin Microbiol Infect 2016; 22: S9–S14Corelation of increasing trends of imipenem-resistance with constituent ratio of K. pneumoniae clinical isolates in China since 2005CHINET DATAConstituent ratioRatio%CR%Imipenem-resistance rateModified from Hu FP, Clin Microbiol Infect 2016; 22: S9–S14Corelation of increasing trends of imipenem-resistance with constituent ratio of A. baumannii clinical isolates in China since 2005Imipenem-resistance rateCHINET DATARatio%CR%Constituent ratioModified from Hu FP, Clin Microbiol Infect 2016; 22: S9–S14Corelation of increasing trends of imipenem-resistance with constituent ratio of P. aeruginosa clinical isolates in China since 2005CHINET DATARatio%CR%Imipenem-resistance rateConstituent ratioModified from Hu FP, Clin Microbiol Infect 2016; 22: S9–S14A report of bacterial resistance in China 2005~2014Antimicrobial resistance in five most common bacteria: E. coli, K. pneumoniae, A. baumannii, P. aeruginosa and S. aureusHu FP, Clin Microbiol Infect 2016; 22: S9–S14主题词MDR、XDR、PDR的定义MDR--Multiple-drug resistant, 多重耐药:对3类或以上在抗菌谱范围内的抗菌药耐药XDR--Extensively drug resistant, 广泛耐药:除1-2个抗菌药敏感外,均耐药PDR--Pan-drug resistant,全(泛)耐药:对当前临床应用的所有抗菌药耐药Magiorakos AP, Clin Microbiol Infect 2012,18: 268OUTLINE肠杆菌科细菌老问题:产ESBL新问题:产碳青霉烯酶非发酵糖细菌习惯了的问题:XDR鲍曼不动杆菌变化不大的问题:铜绿假单胞菌嗜麦芽窄食单胞菌肠杆菌科细菌耐药问题: 最需关注的β-内酰胺酶是ESBLs?超广谱β-内酰胺酶(ESBLs)?高产头孢菌素酶(AmpC酶)?产碳青霉烯酶(KPC、NDM-1等) MDRXDR orPDRPrevalence of ESBL in Enterobacteracae肠杆菌科细菌ESBL检出率CHINET Data 产与非产ESBL

文档评论(0)

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档